NAARDEN, The Netherlands and MIAMI, Jan. 08, 2024 -- NewAmsterdam Pharma Company N.V. , a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of...
NAARDEN, The Netherlands and MIAMI, June 09, 2023 -- NewAmsterdam Pharma Company N.V. , a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of... | June 9, 2023
NAARDEN, the Netherlands and MIAMI, June 06, 2023 -- NewAmsterdam Pharma Company N.V. , a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of... | June 6, 2023
Patient enrollment completed for Phase 3 non-erosive gastroesophageal reflux disease (NERD) daily dosing trial with topline data for primary endpoint...
China’s party congress heightened policy risks that can push its stocks into a prolonged period of valuation compression, said a co-founder of a 22-year-old Asia-focused hedge fund firm.